General experimental section. Analytical grade solvents and reagents were purchased from commercial suppliers and used without further purification. Anhydrous solvents were either purchased (DMF) or dried with activated molecular sieves: CH 3 CN (3 Å) and CH 2 Cl 2 /1,2-dichloroethane/N,N′-diisopropylethylamine (4 Å). Reactions using these solvents were conducted under an inert atmosphere (argon). All reactions were monitored by thin layer chromatography (TLC) using silica gel coated plates with a fluorescence indicator (SiO 2 -60, F-254), which were visualized under UV light and/or by dipping in 5% conc. H 2 SO 4 in abs. ethanol (v/v) followed by heating. Purification (>95% purity, assessed by one-dimensional NMR techniques) was accomplished using column chromatography (silica gel 60, particle size 0.040-0.063 mm) using moderate pressure MALDI-HRMS spectra were recorded on a Q-TOF mass spectrophotometer using 2,5-dihydroxybenzoic acid (DHB) as a matrix. cooling the solution to 0 °C, nucleoside 2 was added and the reaction mixture was warmed to rt over 15 min. Upon completion of the reaction (reaction time specified below) the solvent was evaporated and the resulting residue dissolved in EtOAc (100 mL). The organic phase was sequentially washed with sat. aq. NaHCO 3 (2 × 50 mL) and brine (50 mL), dried (Na 2 SO 4 ) and evaporated to dryness. The resulting residue was purified by silica gel column chromatography (0-5% MeOH in CH 2 Cl 2 , v/v) to afford desired nucleoside 3x/y/z (quantities and yields specified below). 8, 74.8, 59.0, 24.2, 22.8, 20 .9 ppm). We attribute these peaks to the presence of two different conformers, most likely rotamers -rather than scrambling of the chirality center in the amino acid residue -based on the observation that only one set of signals is observed when the spectrum is recorded in acetone-d 6 . vicinity of the amino acid residue).
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5-(TFA-leucyl-aminopropynyl)-5′-O-(4,4′-dimethoxytrityl) LNA uridine (3y). A solution of S-2-(2,2,2-trifluoroacetamido)-4-methylpentanoic
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General phosphitylation protocol for the preparation of 4x/y/z. The appropriate nucleoside 3 was coevaporated with anhydrous 1,2-dichloroethane (2 × 10 mL) and dissolved in anhydrous CH 2 Cl 2 . DIPEA was added to this solution followed by dropwise addition of 2-cyanoethyl N,N-diisopropylchlorophosphoramidite (PCl reagent). The reaction was stirred at rt for 2 h, at which point ice cold ethanol (1 mL) was added and the solvents were evaporated. The resulting residue was purified by silica gel column chromatography (typically 0-5% MeOH/CH 2 Cl 2 , v/v) and subsequent trituration from CH 2 Cl 2 and petroleum ether to provide phosphoramidites 4x/y/z. 
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